The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin

DSpace Repository

The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin

Author: Schittenhelm, Marcus M.; Kampa-Schittenhelm, Kerstin Maria; Yee, Kevin W. H.; Heinrich, Michael C.
Tübinger Autor(en):
Schittenhelm, Marcus Matthias
Kampa-Schittenhelm, Kerstin Maria
Published in: Cell Cycle (2009), Bd. 8, H. 16, S. 2621-2630
Verlagsangabe: Abingdon : Tayler & Francis
Language: English
Full text: http://dx.doi.org/10.4161/cc.8.16.9355
ISSN: 1538-4101
1551-4005
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)